Literature DB >> 10446440

Familial risks in cervical cancer: is there a hereditary component?

K Hemminki1, C Dong, P Vaittinen.   

Abstract

The Swedish Family-Cancer Database was used to analyze familial relationships in mothers and daughters in invasive and in situ cervical cancers from years 1958-1994, including a total of 125,000 in situ and 14,000 invasive cancers. In situ cancers were diagnosed on average 10 years earlier than invasive cancers. Familial relative risks (FRRs) were calculated separately for mothers and daughters, and were between 1.8 and 2.3 for the 2 forms. The risks were only slightly modified by age of onset, except at higher ages where there was no familial risk; in mothers, the risks increased if more than one daughter was affected. Aggregation of in situ cases among sisters was observed in families. Heritability estimates were between 0.11 and 0.15 for in situ and 0.22 and 0.34 for invasive cervical cancer. A comparison of cancers in mothers and daughters showed an association between cervical cancer and many cancer types observed in immunosuppressed patients, suggesting a role for a mild form of immunosuppression, in addition to sexual behavior leading to human-papilloma-virus infections, in familial cervical cancer. Copyright 1999 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  1999        PMID: 10446440     DOI: 10.1002/(sici)1097-0215(19990909)82:6<775::aid-ijc1>3.0.co;2-v

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  22 in total

1.  Age-incidence relationships and time trends in cervical cancer in Sweden.

Authors:  K Hemminki; X Li; P Mutanen
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

2.  Distribution of CCND1 A870G polymorphism in patients with advanced uterine cervical carcinoma.

Authors:  Teresa Warchoł; Lukasz Kruszyna; Margarita Lianeri; Andrzej Roszak; Paweł P Jagodziński
Journal:  Pathol Oncol Res       Date:  2010-08-03       Impact factor: 3.201

3.  TNF-α and IL-10 promoter polymorphisms, HPV infection, and cervical cancer risk.

Authors:  Gisela Barbisan; Luis Orlando Pérez; Anahí Contreras; Carlos Daniel Golijow
Journal:  Tumour Biol       Date:  2012-05-17

4.  Genetic association between CD95 rs2234767 polymorphism and cervical cancer risk: a meta analysis.

Authors:  Ping Liu; Zibai Wei; Xiaofeng He; Junyan Yu; Xiangyang Tian; Jianlan Chang
Journal:  Int J Clin Exp Med       Date:  2015-02-15

Review 5.  Clinical genetic counselling for familial cancers requires reliable data on familial cancer risks and general action plans.

Authors:  K Hemminki; C Eng
Journal:  J Med Genet       Date:  2004-11       Impact factor: 6.318

Review 6.  Vaccines for cervical cancer.

Authors:  C M Lowndes
Journal:  Epidemiol Infect       Date:  2006-02       Impact factor: 2.451

7.  Familial cervical cancer: case reports, review and clinical implications.

Authors:  Margreet Zoodsma; Rolf H Sijmons; Elisabeth Ge de Vries; Ate Gj van der Zee
Journal:  Hered Cancer Clin Pract       Date:  2004-05-15       Impact factor: 2.857

8.  CCR2-V64I polymorphism is associated with increased risk of cervical cancer but not with HPV infection or pre-cancerous lesions in African women.

Authors:  Koushik Chatterjee; Collet Dandara; Margaret Hoffman; Anna-Lise Williamson
Journal:  BMC Cancer       Date:  2010-06-10       Impact factor: 4.430

Review 9.  Genetic susceptibility to cervical cancer: role of common polymorphisms in apoptosis-related genes.

Authors:  Shing Cheng Tan; Ravindran Ankathil
Journal:  Tumour Biol       Date:  2015-08-05

10.  Fas and FasL gene polymorphisms are not associated with cervical cancer but differ among Black and Mixed-ancestry South Africans.

Authors:  Koushik Chatterjee; Malin Engelmark; Ulf Gyllensten; Collet Dandara; Lize van der Merwe; Ushma Galal; Margaret Hoffman; Anna-Lise Williamson
Journal:  BMC Res Notes       Date:  2009-11-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.